EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 370 filers reported holding EXELIXIS INC in Q3 2020. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,375,925 | +11.4% | 4,593,441 | -2.6% | 0.03% | +13.8% |
| Q2 2023 | $90,115,105 | -0.2% | 4,715,692 | +1.4% | 0.03% | -3.3% |
| Q1 2023 | $90,303,938 | +128672.0% | 4,652,832 | +6.4% | 0.03% | +42.9% |
| Q4 2022 | $70,127 | -99.9% | 4,372,328 | +8.3% | 0.02% | -12.5% |
| Q3 2022 | $63,279,000 | -19.6% | 4,035,449 | +6.8% | 0.02% | -14.3% |
| Q2 2022 | $78,688,000 | -7.0% | 3,779,563 | +1.3% | 0.03% | +7.7% |
| Q1 2022 | $84,578,000 | +36.7% | 3,730,929 | +10.3% | 0.03% | +36.8% |
| Q4 2021 | $61,862,000 | +4.5% | 3,383,948 | +20.9% | 0.02% | 0.0% |
| Q3 2021 | $59,184,000 | +52.6% | 2,799,836 | +31.6% | 0.02% | +58.3% |
| Q2 2021 | $38,772,000 | -19.4% | 2,128,130 | +0.0% | 0.01% | -25.0% |
| Q1 2021 | $48,103,000 | +11.1% | 2,127,797 | -1.3% | 0.02% | 0.0% |
| Q4 2020 | $43,282,000 | -19.2% | 2,156,482 | -1.6% | 0.02% | -30.4% |
| Q3 2020 | $53,572,000 | +3.0% | 2,191,092 | -0.0% | 0.02% | 0.0% |
| Q2 2020 | $52,015,000 | +38.6% | 2,191,731 | +0.6% | 0.02% | +15.0% |
| Q1 2020 | $37,524,000 | +1.8% | 2,178,701 | +4.2% | 0.02% | +53.8% |
| Q4 2019 | $36,854,000 | -0.1% | 2,091,520 | +0.2% | 0.01% | -7.1% |
| Q3 2019 | $36,903,000 | -16.1% | 2,086,395 | +1.4% | 0.01% | -17.6% |
| Q2 2019 | $43,980,000 | -6.8% | 2,057,934 | +3.8% | 0.02% | -10.5% |
| Q1 2019 | $47,204,000 | +73.7% | 1,983,380 | +43.6% | 0.02% | +58.3% |
| Q4 2018 | $27,172,000 | +24.0% | 1,381,432 | +11.7% | 0.01% | +50.0% |
| Q3 2018 | $21,913,000 | -18.3% | 1,236,691 | -0.8% | 0.01% | -27.3% |
| Q2 2018 | $26,831,000 | +16.7% | 1,246,895 | +20.1% | 0.01% | +10.0% |
| Q1 2018 | $22,996,000 | -17.5% | 1,038,173 | +13.3% | 0.01% | -16.7% |
| Q4 2017 | $27,864,000 | +103.3% | 916,403 | +62.0% | 0.01% | +100.0% |
| Q3 2017 | $13,706,000 | -10.3% | 565,648 | -8.8% | 0.01% | -14.3% |
| Q2 2017 | $15,273,000 | +19.1% | 620,096 | +4.8% | 0.01% | +16.7% |
| Q1 2017 | $12,826,000 | +61.9% | 591,901 | +11.4% | 0.01% | +50.0% |
| Q4 2016 | $7,922,000 | +1468.7% | 531,353 | +1246.0% | 0.00% | – |
| Q3 2016 | $505,000 | +50400.0% | 39,476 | +9769.0% | 0.00% | – |
| Q2 2014 | $1,000 | -50.0% | 400 | -33.3% | 0.00% | – |
| Q1 2014 | $2,000 | -96.6% | 600 | -93.7% | 0.00% | – |
| Q4 2013 | $58,000 | -25.6% | 9,450 | -29.7% | 0.00% | – |
| Q3 2013 | $78,000 | -95.3% | 13,450 | -96.4% | 0.00% | -100.0% |
| Q2 2013 | $1,673,000 | – | 368,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |